The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease
- 1 January 2014
- journal article
- Published by Elsevier in Human Immunology
- Vol. 75 (1) , 5-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal CarcinomaPLOS ONE, 2013
- On the armament and appearances of human myeloid-derived suppressor cellsClinical Immunology, 2012
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cellsBlood, 2011
- Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology, 2011
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaNeuro-Oncology, 2011
- Myeloid-derived suppressor cell heterogeneity and subset definitionCurrent Opinion in Immunology, 2010
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell CarcinomaClinical Cancer Research, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008